×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
AstraZeneca concludes equity investment in Cellectis
Pharmaceutical Technology
AstraZeneca has concluded an equity investment in clinical-stage biotechnology company Cellectis following a deal signed in November 2023.
3 days ago
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
Yahoo Finance
Completion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023 NEW YORK, May 06,...
4 days ago
AstraZeneca Invests $140M in Cellectis, Secures 44% Stake in CAR-T Specialist
BioSpace
Cell and gene therapy company Cellectis announced Monday it has completed a $140 million investment from AstraZeneca that extends the...
4 days ago
AstraZeneca concludes equity investment in Cellectis
Home - GlobalData
AstraZeneca concludes equity investment in Cellectis. Under their partnership deal, the companies will develop up to ten new cell and gene therapy products.
3 days ago
AstraZeneca completes equity investment agreement with Cellectis
WebWire
AstraZeneca announced the successful completion of an equity investment with Cellectis, a clinical-stage biotechnology company.
2 days ago
AstraZeneca Advances in Gene Therapy with Cellectis Stake - TipRanks.com
Tipranks
AstraZeneca (AZN) has released an update. AstraZeneca has finalized a significant equity investment in Cellectis, a biotech firm...
3 days ago
AstraZeneca invests $140M in Cellectis, raising stake to 44% (NASDAQ:CLLS)
Seeking Alpha
AstraZeneca (AZN) has completed its previously announced $140M investment in Cellectis (CLLS), raising its share capital stake in the gene...
4 days ago
AstraZeneca concludes equity investment in Cellectis
MSN
Under their partnership deal, the companies will develop up to ten new cell and gene therapy products.
3 days ago
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2023
GlobeNewswire
Preliminary results of NATHALI-01 and updated results of BALLI-01 Phase I clinical studies presented at the American Society of Hematology...
1 week ago
Cellectis' open NC plant adds in-house capabilities BioProcess Insider
BioProcess International
France-headquartered Cellectis announced plans in March 2019 to construct a clinical and commercial production plant in Raleigh, North Carolina at a reported...
2 months ago